← Back to Search

Other

Sham at visit 1, TMS at visit 2 for Obsessive-Compulsive Disorder

N/A
Waitlist Available
Led By Kristen Benito, PhD
Research Sponsored by Bradley Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from pre (within 1 hour before) to post (within 1 hour after) intervention
Awards & highlights

Study Summary

This trial will test whether magnetic stimulation of a specific brain area can help reduce symptoms in adolescents with OCD.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from pre (within 1 hour before) to post (within 1 hour after) intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from pre (within 1 hour before) to post (within 1 hour after) intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in frontocentral P3 amplitude on Electroencephalogram (EEG)
Change in response time on stop trials of the stop signal task
Secondary outcome measures
3-item self-report symptom questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Group I: TMS at visit 1, Sham at visit 2Experimental Treatment1 Intervention
At visit 1, participants will receive active TMS using continuous theta burst over the preSMA. At Visit 2, participants will receive sham (fake) TMS in the same location.
Group II: Sham at visit 1, TMS at visit 2Experimental Treatment1 Intervention
At visit 2, participants will receive active TMS using continuous theta burst over the preSMA. At Visit 1, participants will receive sham (fake) TMS in the same location.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Magnetic Stimulation
2017
Completed Phase 4
~730

Find a Location

Who is running the clinical trial?

University of MinnesotaOTHER
1,377 Previous Clinical Trials
1,588,289 Total Patients Enrolled
3 Trials studying Obsessive-Compulsive Disorder
97 Patients Enrolled for Obsessive-Compulsive Disorder
Bradley HospitalLead Sponsor
16 Previous Clinical Trials
1,487 Total Patients Enrolled
3 Trials studying Obsessive-Compulsive Disorder
616 Patients Enrolled for Obsessive-Compulsive Disorder
Butler HospitalOTHER
129 Previous Clinical Trials
16,411 Total Patients Enrolled
12 Trials studying Obsessive-Compulsive Disorder
440 Patients Enrolled for Obsessive-Compulsive Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the qualifications necessary to partake in this experiment?

"To meet the criteria for inclusion, prospective participants should have a diagnosis of obsessive-compulsive disorder and be between 13 to 18 years old. Approximately 25 subjects are required for this trial."

Answered by AI

Does this research project accommodate elderly participants?

"This trial is seeking adolescents aged 13-18 to participate."

Answered by AI

Are there any vacancies available for prospective participants in this clinical experiment?

"Confirmed. The details listed on clinicaltrials.gov demonstrate that this research study, which was launched on April 1st 2022, is actively seeking volunteers. 25 individuals are sought after to take part in the trial at a single medical centre."

Answered by AI

How many individuals have elected to participate in the trial?

"Affirmative. According to the information hosted on clinicaltrials.gov, this research project is presently recruiting participants; its inception was April 1st 2022 and it has been modified most recently on July 7th 2022. 25 patients are needed from a single medical centre."

Answered by AI
~2 spots leftby Apr 2025